Local Anaesthetic Toxicity (AAGBI) Flashcards

1
Q

LAST Incidence

A

1.8 per 1000 Nerve Blocks
Most common causative agent lidocaine
50% of events occur within 10mins of injection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

LAST Emergency Management

A
  • Stop injecting LA
  • Call for help, cardiac arrest trolley and lipid emulsion pack
  • ABCDE

Intralipid
- 20% intralipid bolus 1.5ml/kg over 2-3mins
- Start an infusion of 15ml/kg/hour
- If no improvement then further bolus dose then double the rate of the infusion
- Max cumulative dose 12ml/kg

If circulatory arrest differences to ALS:
- Smaller dose of adrenaline (1mcg/kg) (increases afterload and interferes with intralipid)
- Avoid vasopressin (Worse outcomes in LAST, reduced CO)
- Be aware recovery can take >1 hour
- Consider ECMO

If seizures:
- Small incremental boluses of IV benzodiazepines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pathophysiology of LAST

A
  • LA is likely to be involved in disrupting normal mitochondrial aerobic respiration
  • As the heart and brain are highly intolerant to anaerobic respiration symptoms develop here quickly
  • Direct ionotropic and metabotropic disruption caused by Na channel inhibition also plays a significant role
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Mechanism of action of intralipid

A
  • Directly ionotropic
  • Cardioprotective of reperfusion injury
  • Acts as a “lipid sink” partitions the positively charged lipophilic local anaesthetic inside negatively charged fat molecules and redistributes these to the muscle and liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Follow up following LAST

A
  • Careful observation for at least 6 hours as LA can redistribute
  • If the diangosis is clear and there has been no cardiovascular compromise then elective surgery may be acceptable to continue following an observation window of 30-40mins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Risk Factors for LAST

A

LA RFx
- Type of LA
- Volume and rate of injection
- Where the LA was injected

Patient RFx
- Pre-existing cardiac disease
- Extremes of age
- Pregnancy
- Low muscle mass
- Impaired hepatic function
- Reduced a1- glycoprotein levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Methods to reduce the risk of LAST

A
  • Use the minimum effective dose
  • Extra care in repeat dosing
  • Consider adding adrenaline to reduce systemic uptake
  • US guidance
  • Aspiration before injection
  • NR Fit
  • Awake patients theoretically allows for earlier detection
  • LAST box in areas where LA are given
How well did you know this?
1
Not at all
2
3
4
5
Perfectly